Alliance Pharma PLC
ALAPH.L
$0.59
Closing
▼-0.11%
1D
▲11.11%
YTD
ALAPH
BBG001S5TBM5
Market cap
$317.83M
52 week high
$0.61
52 week low
$0.32
Volume
726,291
Check if the stock is halal
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $6.99/month
Market cap
$317.83M
Analysts' Rating
BUY
Price Target (Mean)
0.85
Total Analysts
0
P/E
Operating Margin
12.78%
Beta
0.83
Revenue Growth
3.03%
52 week high
$0.61
52 week low
$0.32
Div. Yield
0.00%
EPS Growth
0.00
Company Profile
Alliance Pharma plc is a United Kingdom-based consumer healthcare company. The principal activity of the Company is to act as a holding company. The principal activity of the Company is the acquisition, marketing and distribution of consumer healthcare and pharmaceutical products. The Company’s segments are strategic business units that represent different parts of the overall product portfolio, these being Consumer Healthcare brands and Prescription Medicines. Its Consumer Healthcare brands include Kelo-Cote franchise, Amberen, Nizoral, MacuShield, Aloclair, Vamousse, and other consumer healthcare brands. Its Prescription Medicines include Hydromol, Flamma Franchise, Forceval and other prescription medicines. Its products include Aloclair Plus Gel, Changmin, Fazol Cream, Hydromol Ointment, Kelo-Stretch Cream, and others. It holds the marketing rights to around 80 Consumer Healthcare brands and Prescription Medicines, which are sold around the world in more than 100 countries.
